celastrol methyl ester has been researched along with (1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol in 1 studies
Studies (celastrol methyl ester) | Trials (celastrol methyl ester) | Recent Studies (post-2010) (celastrol methyl ester) | Studies ((1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol) | Trials ((1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol) | Recent Studies (post-2010) ((1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol) |
---|---|---|---|---|---|
39 | 0 | 27 | 17 | 0 | 12 |
Protein | Taxonomy | celastrol methyl ester (IC50) | (1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol (IC50) |
---|---|---|---|
XBP1 | Homo sapiens (human) | 4.76 | |
DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 2.53 | |
Epidermal growth factor receptor | Homo sapiens (human) | 0.7944 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.7221 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.4004 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 4.561 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 4.4868 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.0232 | |
Adenosine receptor A3 | Homo sapiens (human) | 3.7058 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.505 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 4.9963 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.7058 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.446 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.5435 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 4.6238 | |
Substance-K receptor | Homo sapiens (human) | 6.7929 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.4004 | |
Histamine H2 receptor | Homo sapiens (human) | 0.1081 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.5435 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.2532 | |
Histamine H1 receptor | Homo sapiens (human) | 5.1768 | |
D(3) dopamine receptor | Homo sapiens (human) | 2.1039 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.939 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.7058 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.57 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.1172 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y | 1 |
1 other study(ies) available for celastrol methyl ester and (1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol
Article | Year |
---|---|
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites | 2011 |